Immuno-Oncology Summit Boston 2023
September 11, 2023
August 7-9, 2023 – Boston, MA
Presentation: Improving T-Cell Performance in Solid Tumors
Menu
7th CAR-TCR Summit
September 1, 2022
September 19-22, 2022 – Boston, MA
Presentation: Developing Versatile T-cell Therapies Against Extracellular, Intracellular & Planted Targets for the Treatment of Solid Tumors
Panel Discussion: New Frontiers in Cell Therapy – Optimizing Combined Approaches for Greater Persistence
3rd Gamma Delta T Therapies Summit
July 25, 2022
July 26-28, 2022 – Embassy Suites Boston Logan Airport, Boston, MA
Harnessing Gamma Delta TCR Signaling and Alpha Beta T Cell Biology for Cancer Therapy
The Onco Cell Therapy Summit
July 25, 2022
June 29-30, 2022 – Boston, MA
Developing a Versatile T-Cell Engineering Platform Capable of Accessing Extracellular, Intracellular and Planted Targets for the Treatment of Solid Tumors
TCR-based Therapies for Solid Tumors Summit
July 25, 2022
June 27-29, 2022 – Boston, MA
Improving T Cell Performance in Solid Tumors with an Engineered Antibody T-Cell Receptor (AbTCR)
PEGS Boston 2022
July 25, 2022
May 2-6, 2022 – Hynes Convention Center, Boston, MA
Roundtable: Targeting Intracellular Antigens – Challenges and Opportunities
Cellular Immunotherapies for Solid Tumors Summit
July 25, 2022
November 16-18, 2021 – Virtual
Overcoming Solid Tumor Challenges with ARTEMIS Antibody Redirected T-Cell Therapy
Precision Blood Cancer
July 25, 2022
September 29-30, 2021 – Virtual
CD19/CD22 Dual-Targeting ARTEMIS Antibody Redirected TCR T-Cell Therapy for the Treatment of Hematological Malignancies
CAR-TCR Summit 2021
July 25, 2022
August 30-September 2, 2021 – Virtual
ARTEMIS T Cells: Targeting, Infiltrating and Surviving in Solid Tumors
TCR-based Therapies Summit
July 25, 2022
June 8-10, 2021 – Virtual
ARTEMIS Technology with Enhanced T-Cell Infiltration in Solid Tumors
